Eyenovia, Inc. (EYEN)
NASDAQ: EYEN · Real-Time Price · USD
12.08
+1.52 (14.39%)
Jul 2, 2025, 10:43 AM - Market open
Eyenovia Employees
As of December 31, 2024, Eyenovia had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 43 or -75.44% compared to the previous year.
Employees
14
Change (1Y)
-43
Growth (1Y)
-75.44%
Revenue / Employee
$4,790
Profits / Employee
-$3,027,133
Market Cap
61.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
EYEN News
- 13 days ago - Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings - PRNewsWire
- 14 days ago - Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group - GlobeNewsWire
- 14 days ago - Eyenovia Surges on Crypto Announcement - Market Watch
- 14 days ago - Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy - GlobeNewsWire
- 6 weeks ago - Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Eyenovia Provides Development Update on Optejet User Filled Device (UFD) - GlobeNewsWire
- 3 months ago - Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewsWire
- 4 months ago - Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewsWire